Andreessen Horowitz works with Julie Yoo as basic partner thumbnail

Andreessen Horowitz works with Julie Yoo as basic partner

Julie Yoo has joined Andreessen Horowitz as its newest general partner. She will make investments out of the venture capital firm’s bio fund, which closed on $450 million in 2017. Yoo spent the last eight years as a co-founder and chief product officer of Kyruus, a venture-backed healthcare provider matching tool. She’s joins as a16z’s…

Julie Yoo has actually signed up with Andreessen Horowitz as its most recent basic partner. She will make investments out of the venture capital firm’s bio fund, which closed on $450 million in 2017.

Yoo spent the last eight years as a co-founder and primary item officer of Kyruus, a venture-backed doctor matching tool. She’s joins as a16 z’s 17 th GP; the company employed David George, who concentrates on late-stage offers, and Anish Acharya, who concentrates on fintech offers, as GPs earlier this year.

More especially, Yoo ends up being the fourth female general partner at a company that for many years had only guys at the top of its ranks. The Slack investor employed its first-ever female GP, Katie Haun, in June 2018 to lead its crypto efforts along with Chris Dixon. Long time a16 z investors Connie Chan and Angela Strange were later on promoted to GP.

Yoo joins Vijay Pande and Jorge Conde on a16 z’s biotech investment team. The trio will focus on life sciences, artificial bio and more comprehensive health tech.

Julie Yoo Square

a16 z’s newest basic partner, Julie Yoo

” As we have actually focused on these three areas we’ve realized it’s a quite broad opportunity,” Conde tells TechCrunch. “W e desired to discover a GP that had the phenotype of what we try to find in all of our GPs … and somebody who has deep operating proficiency that knows how to build companies.”

Prior to co-founding Kyruus, Yoo was the vice president of item at Generation Health, a CVS-acquired health management company. In her very first function as an investor, Yoo says she will recognize financial investments in business changing access to our healthcare system.

” We are an extension of the phrase ‘software is eating the world,'” Yoo informs TechCrunch. “We are concentrated on software application eating care shipment and whatever that flows from that.”

Amongst a16 z’s health and bio financial investments is Devoted Health, which helps Medicare beneficiaries gain access to care through its network of physicians and tech-enabled healthcare platform. Other investments in the area include Freenome, a liquid biopsy diagnostics platform; Apeel, that makes a sort of plant food-based barrier for fruit that aims to replace wax finishings; a care coordination network called PatientPing; and BioAge Labs, a company that’s trying to find drugs that extend human beings’ health span through artificial intelligence and biomarkers that speed up the discovery procedure.

Learn More